Next-generation test strip including ACR

Urine analysis is one of the most widely used diagnostic methods in clinical practice highlighting demand for solutions that guarantee exceptional accuracy, precision, and reliability. As chronic kidney disease (CKD) cases continue to rise globally, efforts to strengthen diagnosis and promote early detection are essential. UDStrip-12 establishes a new benchmark in routine urine diagnostics, combining the 10 most common parameters with albumin and creatinine determination on a single strip. This combination enables calculation of the albumin-to-creatinine ratio (ACR), a key marker recommended by the latest KDIGO guidelines for early CKD detection. With this and unlike conventional strips, UDStrip-12 allows comprehensive kidney screening during routine testing.

Follow, to read more about ACR determination.

The albumin-to-creatinine ratio (ACR) is one of the two core criteria recommended by the KDIGO 2024 guideline for diagnosing and staging chronic kidney disease (CKD). Detecting kidney damage early is critical for preventing progression and minimizing complications. Since urinary albumin typically appears well before symptoms, its determination is vital for timely intervention. Routine determination of albumin in urine, combined with creatinine measurement, allows accurate ACR calculation and provides a reliable indicator of kidney damage. Integrating ACR into standard urine testing ensures comprehensive screening for all patients—not just high-risk groups—improving outcomes and supporting timely intervention. UDStrip-12 simplifies this process by combining general parameters with albumin and creatinine on a single strip, enabling efficient CKD risk assessment during routine diagnostics.